251 results on '"Meyers, Gabrielle"'
Search Results
2. Transplantation-Associated Altered Mentation and Encephalopathy: A New Classification for Acute Neurocognitive Changes Associated with Hematopoietic Cell Transplantation from the ASTCT Committee on Practice Guidelines
3. Assessment of Mobility Trajectories Using Wearable Inertial Sensors During Autologous Hematopoietic Cell Transplant
4. Frailty and Preoperative Palliative Care in Surgical Oncology
5. A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease
6. Allogeneic immunity clears latent virus following allogeneic stem cell transplantation in SIV-infected ART-suppressed macaques
7. Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia
8. Day 4 collection of granulocyte colony-stimulating factor-mobilized HLA-matched sibling donor peripheral blood allografts demonstrates no long-term increase in chronic graft-versus-host disease or relapse rates
9. Delivering exercise medicine to cancer survivors: has COVID-19 shifted the landscape for how and who can be reached with supervised group exercise?
10. Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial
11. Drug-induced and malignancy-associated neutrophilic dermatoses in patients with hematologic malignancies: A single institution experience
12. Access to Allogeneic Hematopoietic Cell Transplant for Patients with Hematologic Malignancies in Oregon
13. Impact of ABO Compatibility on Outcomes after Allogeneic Hematopoietic Cell Transplantation (HCT): Ptcy Impacts Platelet Engraftment, Independent of ABO Compatibility
14. The Impact of Telehealth Visits on Access to Transplant Care for Recipients of Allogeneic Hematopoietic Cell Transplantation in the State of Oregon
15. Feasibility and cost analysis of day 4 granulocyte colony-stimulating factor mobilized peripheral blood progenitor cell collection from HLA-matched sibling donors
16. Lessons learned from early closure of a clinical trial for steroid-refractory acute GVHD
17. FEASIBILITY OF CONTINUOUS PASSIVE MONITORING OF DAILY FUNCTION AND SYMPTOMS IN OLDER ADULTS WITH MULTIPLE MYELOMA
18. Outcomes of Autologous Hematopoietic Cell Transplantation in Older Patients with Diffuse Large B-Cell Lymphoma
19. MDS-009 Enhanced Survival of Chronic Myelomonocytic Leukemia (CMML)-Dysplastic Over the Proliferative Subtype After Allogeneic Hematopoietic Cell Transplantation: A Tertiary Center Experience
20. POSTER: MDS-009 Enhanced Survival of Chronic Myelomonocytic Leukemia (CMML)-Dysplastic Over the Proliferative Subtype After Allogeneic Hematopoietic Cell Transplantation: A Tertiary Center Experience
21. Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or Relapse
22. Graft Failure
23. Overall Survival in Myelofibrosis Treated with Allogeneic Hematopoietic Cell Transplant Is Impacted By Reversal of Marrow Fibrosis: A Single Institution Experience from Oregon Health and Science University
24. Circulating Angiogenic Factors Associated with Response and Survival in Patients with Acute Graft-versus-Host Disease: Results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802
25. Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Phase 1 Trial
26. Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of Patients with Hematologic Malignancies Using Busulfan, Fludarabine, and Total Body Irradiation Conditioning Is Effective in an Elderly and Infirm Population
27. Graft Failure
28. Induction Bortezomib in AL Amyloidosis Followed By High Dose Melphalan and Autologous Stem Cell Transplantation: A Single Institution Retrospective Study
29. Bacterial Infections Post-Allogeneic Transplant Are Associated with Higher Relapse Related Mortality
30. Control of an Outbreak of Human Parainfluenza Virus 3 in Hematopoietic Stem Cell Transplant Recipients
31. Lessons learned from early closure of a clinical trial for steroid-refractory acute GVHD
32. Delivering exercise medicine to cancer survivors: has COVID-19 shifted the landscape for how and who can be reached with supervised group exercise?
33. FLT3-Mutated Acute Myeloid Leukemia Using a Novel Regimen of Gemtuzumab Ozogamicin and Midostaurin in Combination with Standard Cytarabine and Daunorubicin Induction Therapy
34. Success and Satisfaction with Virtual Hematology Curriculum Implemented in Response to COVID-19
35. 171 - Allogeneic Stem Cell Transplantation in Treatment Related and Secondary Acute Myeloid Leukemia and Myelodysplastic Syndrome: Ohsu Experience
36. Myelodysplasia and Acute Leukemia as Late Complications of Marrow Failure: Future Prospects for Leukemia Prevention
37. The Management of Paroxysmal Nocturnal Hemoglobinuria: Recent Advances in Diagnosis and Treatment and New Hope for Patients
38. Prognostic Significance of NCAM1 (CD56) Expression in AML Patients Treated with HMA+Venetoclax
39. Acute Myeloid Leukemia Differentiation State and Genotype Influence Anti-Apoptotic Protein Expression, Venetoclax Sensitivity, and Survival in AML
40. Allogeneic Stem Cell Transplantation in Treatment Related and Secondary Acute Myeloid Leukemia and Myelodysplastic Syndrome: Ohsu Experience
41. Management Issues in Paroxysmal Nocturnal Hemoglobinuria
42. Molecular basis of clonal expansion of hematopoiesis in 2 patients with paroxysmal nocturnal hemoglobinuria (PNH)
43. Graft Failure
44. 156 - Overall Survival in Myelofibrosis Treated with Allogeneic Hematopoietic Cell Transplant Is Impacted By Reversal of Marrow Fibrosis: A Single Institution Experience from Oregon Health and Science University
45. Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years
46. Early Infection after Allogeneic Transplant Increases NRM without Influencing Relapse Rate
47. 450 - Bacterial Infections Post-Allogeneic Transplant Are Associated with Higher Relapse Related Mortality
48. Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complications
49. Donor T cell chimerism correlates with viral reservoir clearance following allogeneic stem cell transplantation in fully cART-suppressed Mauritian cynomolgus macaques
50. Retrospect Reviews of PNH Tests with Long-Term Follow-up in a Single Institution
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.